Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Establishment Of Prediction Model For Mortality Risk Of Pancreatic Cancer: A Retrospective Study.

Establishment of prediction model for mortality risk of pancreatic cancer: a retrospective study.

Raoof Nopour1

  • 1Department of Health Information Management, Student Research Committee, School of Health Management and Information Sciences Branch, Iran University of Medical Sciences, Tehran, Iran. raoof.n1370@gmail.com.

BMC Medical Informatics and Decision Making
|June 27, 2024

Related Experiment Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.5K

View abstract on PubMed

Summary
This summary is machine-generated.

Early prediction of pancreatic cancer (PC) mortality is crucial. The XG-Boost machine learning model effectively predicts PC mortality risk, identifying tumor size, smoking, and chemotherapy as key factors.

Area of Science:

  • Oncology
  • Machine Learning
  • Biostatistics

Background:

  • Pancreatic cancer (PC) has high prevalence and mortality rates.
  • Early prediction of PC is vital for improving patient prognosis and survival.
  • Current prediction models require enhancement for clinical utility.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting pancreatic cancer mortality risk.
  • To identify key prognostic factors influencing PC mortality.
  • To assess the performance of various machine learning algorithms in PC mortality prediction.

Main Methods:

  • Retrospective analysis of 654 pancreatic cancer cases (alive and deceased).
  • Development of prediction models using six machine learning algorithms.
Keywords:
Machine learningMortality riskPancreatic cancerPrediction model

Related Experiment Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.5K
  • Assessment of prognostic factor importance using a high-performing algorithm (XG-Boost).
  • Main Results:

    • The XG-Boost model demonstrated strong predictive performance with AU-ROC of 0.933 (internal) and 0.836 (external validation).
    • Tumor size, smoking status, and chemotherapy were identified as the most influential predictors of PC mortality.
    • The model's performance was validated through internal and external datasets.

    Conclusions:

    • The XG-Boost model offers superior performance for predicting pancreatic cancer mortality risk.
    • This predictive model can aid clinicians in healthcare settings to reduce patient mortality.
    • Machine learning approaches show promise for enhancing clinical decision-making in pancreatic cancer care.
    Prognostic factors